FDA Inspection 653083 — Aquestive Therapeutics

Aquestive Therapeutics — FEI 3004395604

The FDA completed an inspection of Aquestive Therapeutics on Mar 23, 2010 in Portage, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 23, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Portage, IN (United States)